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Sarcoplasmic reticulumHeart failure (HF) is commonly associated with reduced cardiac output and an increased risk of atrial arrhyth-
mias particularly during β-adrenergic stimulation. The aim of the present study was to determine how HF alters
systolic Ca2+ and the response toβ-adrenergic (β-AR) stimulation in atrialmyocytes. HFwas induced in sheepby
ventricular tachypacing and changes in intracellular Ca2+ concentration studied in single left atrial myocytes
under voltage and current clamp conditions. The followingwere all reduced inHF atrialmyocytes; Ca2+ transient
amplitude (by 46% in current clamped and 28% in voltage clamped cells), SRdependent rate of Ca2+ removal (kSR,
by 32%), L-type Ca2+ current density (by 36%) and action potential duration (APD90 by 22%). However, in HF SR
Ca2+ content was increased (by 19%) when measured under voltage-clamp stimulation. Inhibiting the L-type
Ca2+ current (ICa-L) in control cells reproduced both the decrease in Ca
2+ transient amplitude and increase of
SR Ca2+ content observed in voltage-clamped HF cells. During β-AR stimulation Ca2+ transient amplitude was
the same in control and HF cells. However, ICa-L remained less in HF than control cells whilst SR Ca2+ content was
highest in HF cells during β-AR stimulation. The decrease in ICa-L that occurs in HF atrialmyocytes appears to under-
pin the decreased Ca2+ transient amplitude and increased SR Ca2+ content observed in voltage-clamped cells.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).1. Introduction
Heart failure (HF) remains a leading cause of morbidity and mortal-
ity [1] as well as a major risk factor for the development of atrial ﬁbril-
lation (AF) [2]. In the healthy heart atrial contraction increases
ventricular ﬁlling and thus cardiac output by approximately 20% [3]. In
HF however, the atrial contribution to ventricular ﬁlling is reduced
and thus reduced atrial contractility contributes to the reduction in car-
diac output observed in HF [4]. Whilst the cellular mechanisms leading
to reduced contractility in the ventricle in HF have been extensively
studied e.g. [5–9], the cellular changes that occur in the atria as result
of the development of HF, and how these may contribute to atrial dys-
function in HF, are less well-understood.
Atrial remodelling as a result of HF could lead to reduced atrial con-
tractility and an increased propensity for arrhythmias in at least three
generalways; i) through changes to cellular Ca2+ homeostasis reducing
the amplitude of the systolic Ca2+ transient or via facilitation of delayed(A.W. Trafford).
. This is an open access article underafter-depolarizations (DADs) [10], ii) via action potential shortening
which could arise as a consequence of changes in the systolic Ca2+ tran-
sient or ion channel remodelling (reviewed in [11]) and, iii) as a result of
extracellular matrix remodelling leading to ﬁbrosis, increased tissue
stiffness and conduction block [12]. There are several reports that the
atrial L-type Ca2+ current (ICa-L) is reduced in HF [13–16]. Given the im-
portance of ICa-L in triggering Ca2+ release from the sarcoplasmic retic-
ulum (SR) [17,18], the reduction of atrial ICa-L is potentially signiﬁcant as
it will ﬁrstly reduce the amplitude of the systolic Ca2+ transient and
thus contractility as well as shortening action potential duration
(APD) [19] and atrial effective refractory period thus potentially facili-
tating re-entrant arrhythmia formation [11].
Despite the extensive data showing that ICa-L is reduced in the atria
in various disease settings, there remains a paucity of information re-
garding how cellular Ca2+ handling is quantitatively altered in the
atria in HF and the impact that changes in ICa-L have on SR Ca2+ content
and the systolic Ca2+ transient. Using a brief period of rapid ventricular
pacing in the dog, Yeh et al. [20] demonstrated larger Ca2+ transients
that were attributed to increased SR Ca2+ loading (measured qualita-
tively) and a prolonged action potential duration in ‘HF’myocytes; how-
ever, a role for changes in ICa-L, or other Ca2+ homeostatic mechanisms
such as SERCA activity and Ca2+ buffering [5,21] was not examined.the CC BY license (http://creativecommons.org/licenses/by/3.0/).
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diac contractility and the initiation of arrhythmias [22–24]. However,
apart from limited studies on the effects of β-adrenergic (β-AR) stimu-
lation on atrial ICa-L in cardiac disease states [16,25,26], how β-AR stim-
ulation modulates systolic Ca2+, SR Ca2+ content and cellular Ca2+
homeostasis in the atria during HF is unknown.
Thus, the objectives of the present studywere to assess the impact of
HF on atrial myocyte intracellular Ca2+ homeostasis, systolic Ca2+ and
SR Ca2+ content and how these are modiﬁed by β-AR stimulation. We
used an ovinemodel of dilated cardiomyopathy produced by rapid ven-
tricular pacing and found that HF leads to a shortening of the atrial ac-
tion potential duration (APD) and reduction in Ca2+ transient
amplitude but SR Ca2+ content, determined from the amplitude of the
caffeine evoked rise of [Ca2+]i, was unaltered. Under voltage clamp con-
ditions the Ca2+ transient remained smaller in HF and this occurred due
to a reduction in ICa-L rather than a decrease in SR Ca2+ content, which
was paradoxically increased. During β-AR stimulation the Ca2+ transient
was increased more in HF than control cells. However, whilst SR depen-
dent Ca2+ removal and ICa-L were both augmented by β-AR stimulation
in HF cells, they remained reduced compared to control cells. Interesting-
ly, SR Ca2+ content was highest in voltage-clamped HF atrial cells during
β-AR stimulation. In action potential clampedmyocytes the shortenedHF
APD does not explain the smaller systolic Ca2+ transient. We therefore
conclude that the decreased ICa-L in HF atrial myocytes is the major factor
causing the smaller systolic Ca2+ transient.
2. Methods
All procedures were in accordance with The United Kingdom Ani-
mals (Scientiﬁc Procedures) Act, 1986 and European Union Directive
2010/63. Institutional approval was received from The University of
Manchester Animal Welfare and Ethical Review Board.Fig. 1.Action potential duration and Ca2+ transient amplitude are reduced inHF atrialmyocytes
(left) andHF (right) atrialmyocytes following current clamp stimulation at 0.5 Hz, 37 °C. B.Mea
rise of [Ca2+]i (ii). C. Example action potentials from a control and HF cell (i) and, summary daA detailed description of the experimental methods used in this
study is available in the online supplement.
2.1. Experimental heart failure
HF was induced in 25 female Welsh sheep (35.2 ± 1.3 kg, ~18
months of age) by transvenous right ventricular tachypacing as
described in detail previously [5,27,28]. For surgical procedures
anaesthesia was induced and maintained by isoﬂurane inhalation
(1–4% v/v) and perioperative analgesia (meloxicam, 0.5 mg/kg)
and antibiosis (enroﬂoxacin, 2.5 mg/kg) were provided. Animal wel-
fare and the clinical signs indicating the onset of HF were monitored
at least once daily. On development of signs of HF (lethargy, dys-
pnoea and cachexia), ventricular tachypacing was stopped and para-
sternal echocardiography was performed on conscious unsedated
animals gently restrained in a sitting position. Animals were killed by
intravenous administration of pentobarbitone (200 mg/kg) mixed
with heparin (10,000 IU) to prevent coagulation in the coronary vascu-
lature. Age and weight-matched animals were used as controls for the
study. Animals were randomly assigned to the control or HF arms of
the study and once enrolled, no animals were subsequently excluded
from analyses.
2.2. Isolated myocyte studies
All experiments (except cell volume measurements, Supplemental
Fig. S.I) were performed at 37 °C. Changes in intracellular Ca2+ concen-
tration ([Ca2+]i) were monitored using the acetoxymethyl ester of
either Fluo-5F (5 μM; Figs. 2, 3 & 5) or Fura-2 (5 μM; Figs. 1, 4 & 7).
Where Fluo-5F was used to measure [Ca2+]i we were unable to reliably
obtain Ca2+ saturated ﬂuorescence values and therefore changes in
[Ca2+]i were calibrated by determining the resting [Ca2+]i in Fura-2. A. Representative systolic and caffeine evoked Ca2+ transients from Fura-2 loaded control
n data summarizing Ca2+ transient amplitude (i) and, the amplitude of the caffeine evoked
ta for action potential repolarization times (ii). ⁎P b 0.05; ⁎⁎⁎P b 0.001.
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system; Molecular Probes, Invitrogen UK), and then calibrated as origi-
nally described by Cheng et al. [30] assuming a Kd for Ca2+ of 1035
nmol/l [31]. Single atrial myocytes were current or voltage-clamped
using the perforated patch technique with amphotericin-B (240 μg/ml)
[7,32,33]. The surface area to volume ratio (Supplementary data
Fig. S.I) was calculated in calcein-AM (20 μmol/l) loaded cells as
described previously [32].
SR Ca2+ content was calculated by the rapid application of
10 mM caffeine and integration of the resulting Na+–Ca2+ ex-
change (NCX) current [7,32–34]. The Ca2+ buffering capacity of
cells was also obtained from the caffeine evoked Ca2+ transients
[21,32,35].
2.3. Immunoblotting
Left atrial tissue was snap frozen and stored in liquid N2 until use.
Samples were prepared in RIPA buffer and subject to denaturing
SDS-PAGE as described previously [5,32,36]. The expression of the
so-called ‘house-keeping’ proteins β-actin and GAPDH were altered
in this model of HF (Supplementary data Fig. S.II). We therefore
used an internal standard on all blots. This internal standard was
obtained from a single control animal and used to normalize protein
expression on each gel [5,28]. Three replicate gels were obtained and
data averaged for each sample. Details of protein loading, antibody
concentrations and sources are provided in the online supplementa-
ry information.
2.4. Statistics
Initial estimates of sample sizes were determined by power analysis
using Sigmaplot 11 (Systat Software Inc., USA) assuming α= 0.05 and
β= 0.8 and were based on the level of effects and standard deviations
observed previously in this model [5,27,28,37]. Normality of data distri-
butionwas assessed using the Kolmogorov–Smirnov statistic (IBM SPSS
Statistics v20). Data are expressed either as mean ± standard error of
the mean (SEM) for normally distributed data or as the median (inter-
quartile range) for non-normally distributed data from n cells and N
animals (e.g. n/N control; n/N HF). Continuous scale data was log10
transformed [38] and differences between control and HF animals
determined using linear mixed modelling to account for instances
where multiple cellular observations (n) were obtained from each
experimental subject (N) (IBM SPSS Statistics v20). Where treat-
ments/effects were within the same animal, cellular differences were
assessed using a paired Students t-test and considered signiﬁcant
when P b 0.05.
3. Results
3.1. Cardiac and cellular remodelling in heart failure
Clinical signs of HF (lethargy and dyspnoea) were present after a
median 33.5 (29.8–37) days of tachypacing. Due to the anatomic orien-
tation of the cardiac apex over the sternum in sheep we were unable to
obtain trans-thoracic four-chamber views and thus measures of atrial
dimensions or E/A ratios. However ventricular dilatation was present
as we have found previously [5]. In the animals used in the present
study left ventricular internal diastolic dimension increased by 47.2 ±
8.3% and fractional shortening decreased by 57.1 ± 1.9% (both P b
0.001). Atrial cellular hypertrophy was noted in isolated left atrial
myocytes (Supplementary Fig. SI.A) with an increase in planar width
from 15.0 ± 0.2 to 18.1 ± 0.4 μm and length from 127.5 ± 1.7 to
168.5 ± 3.5 μm (both P b 0.001; 347/23 control; 110/9 HF). Membrane
capacitance also increased from 59.6 ± 2.1 to 125.9 ± 9.3 pF (Supple-
mentary Fig. SI.B, P b 0.001). From simultaneously derived confocal
3-dimensional rendered cell volumes and membrane capacitancemeasurements [32,39], the depth of the cells increased in HF (con-
trol, 9.5 ± 0.4 μm; HF 16.5 ± 1.1 μm, P b 0.001. 19/5 control; 15/5
HF). However, the calculated surface area to volume ratio was unal-
tered (control, 5.06 ± 0.17 pF/pl; HF, 4.89 ± 0.26 pF/pl. P = 0.58).
The respective surface area to volume ratio was used to express all
integrated cellular Ca2+ ﬂuxes and SR Ca2+ contents to total cellular
volume [7,33].
3.2. Decreased atrial Ca2+ transient amplitude and action potential duration
in heart failure
We ﬁrst sought to determine if the cellular hypertrophy and chamber
dilatation were associated with alterations to the systolic Ca2+ transient.
Under current clamp conditions, action potential evoked systolic Ca2+
transients were elicited at 0.5 Hz and representative traces shown in
Fig. 1A. Diastolic [Ca2+]i was reduced in current-clamped HF myocytes
control, 60.7 ± 4.5; HF, 37.3 ± 4.8 nmol/l, P= 0.001. However, the am-
plitude of the action potential evoked rise of systolic Ca2+ was reduced
in HF atrial myocytes by 46 ± 17% (Fig. 1B.i, P b 0.05; 18/6 control; 16/
5 HF). Conversely, despite the smaller systolic rise of [Ca2+]i, the ampli-
tude of the caffeine evoked rise of [Ca2+]i, used as a qualitative measure
of SR Ca2+ content, was unaltered following current clamp stimulation
(Fig. 1B.ii). The reduction in systolic Ca2+ was however associated with
a shortening of the action potential duration in HF atrial myocytes
(Fig. 1C, P b 0.001) with the time to 90% repolarization decreasing from
357 ± 26 ms in control to 280 ± 15 ms in HF.
We then sought to determine the potential mechanisms by which
the systolic Ca2+ transient amplitude was reduced in HF atrial
myocytes. In the ﬁrst series of experiments the action potential clamp
technique was used to apply the averaged control and HF action poten-
tial waveforms to myocytes isolated from control atria (Supplementary
material, Fig. S.III). Following stimulation with the HF atrial action po-
tential there was no detectable change in the amplitude of the systolic
Ca2+ transient or caffeine-evoked rise of [Ca2+]i or SR Ca2+ content
measured from the integral of the NCX current following caffeine appli-
cation (Supplementary data, Fig. S.III). Thus, changes in action potential
duration do not explain the smaller atrial systolic Ca2+ transients
observed in this model of HF.
We then performed voltage clamp experiments to facilitate quanti-
tative analysis of ICa-L, cellular Ca2+ ﬂuxes and SR Ca2+ content. Repre-
sentative Ca2+ transients following steady-state voltage clamp
stimulation are illustrated in Fig. 2A. On average the amplitude of the
atrial systolic Ca2+ transient was reduced by 28 ± 9% (Fig. 2B.i, P b
0.05; 43/16 control; 21/10 HF). Given the strong dependence of Ca2+
transient amplitude on SR Ca2+ content and the indication, from the
slowed decay of [Ca2+]i in HF (Fig. 2B.ii) that SERCA activity is impaired,
we next investigated if the decrease of Ca2+ transient amplitude was
due to a fall of SR Ca2+ content. Following steady-state stimulation, caf-
feine (10 mmol/l) was applied rapidly to the cell and the resulting NCX
current integrated. This data is summarized in Fig. 3A. In HF atrial
myocytes SR Ca2+ content was increased from 83.9 ± 4.5 to 100.1 ±
6.7 μmol/l (P b 0.05; 24/8 control; 17/10 HF). Therefore, the reduced
Ca2+ transient amplitude observed in HF atrial cells cannot be
explained by a decrease of SR Ca2+ content.
Another possible explanation for the smaller systolic Ca2+ transients
observed in HF atrial cells would be an increase in the Ca2+ buffering
power of the cells. Representative Ca2+ buffering curves are illustrated
in Fig. 3B.i. The relationship between total and free Ca2+ is shallower in
the HF atrial cells (Fig. 3B.ii, control, 565 ± 35; HF, 318 ± 42). On aver-
age the Ca2+ buffering power of the cells (ratio of total to free Ca2+)was
reduced by 43.7±8.2% inHF (P b 0.001; 24/9 control; 17/10). Therefore,
as with SR Ca2+ content, changes in Ca2+ buffering power do not
explain the smaller systolic Ca2+ transient in HF atrial cells.
The dependence of NCX on [Ca2+]i was also assessed from the caf-
feine evoked rise of [Ca2+]i. The representative traces and summary
data (Fig. 3C) show that less NCX current is produced for a given change
Fig. 3. SR Ca2+ content is increased and cellular Ca2+ buffering power reduced in HF atria. A. (i) Quantiﬁcation of SR Ca2+ content in voltage-clamped control (left) and HF (right) atrial
cells. Following steady state-stimulationmembrane potentialwas held at−40mV and10mmol/l caffeine applied rapidly as indicated to discharge the SR store resulting in an inwardNCX
current (middle panels) whichwas integrated (lower panels) to quantify SR Ca2+ content. (ii) Mean data for SR Ca2+ content. B. (i) Representative Ca2+ buffer slopes from the cell types
indicated. Data obtained by plotting total Ca2+ ([Ca2+]T, ordinate) as a function of [Ca2+]i (abscissa). Total Ca2+ and [Ca2+]i are both derived from caffeine evoked Ca2+ transient. The
broken lines ﬁtted through the original data are best-ﬁt linear regressions. (ii) Summary data showingmean data for cellular Ca2+ buffering power (β). C. (i) Representative data showing
the relationship between NCX current (INCX) and [Ca2+]i obtained during the decay phase of the caffeine-evoked Ca2+ transient. The broken lines through the original data are best-ﬁt
linear regressions. (ii). Mean data for the slope of the linear regression applied to the INCX–[Ca2+]i relationship. ⁎P b 0.05; ⁎⁎⁎P b 0.001.
Fig. 2.Reduced Ca2+ transient amplitude and slowed relaxation in voltage-clampedHF atrialmyocytes. A. Representative systolic Ca2+ transients from a control (left) andHF atrial (right)
myocyte. Cellswere voltage-clamped, stimulated from a holding potential of−40mVwith a 100ms, 50mV step at 0.5 Hz, 37 °C and changes in [Ca2+]imeasuredwith Fluo-5F. B. (i)Mean
data summarizing changes in Ca2+ transient amplitude. (ii) Superimposed Ca2+ transients from representative control andHF atrial cells demonstrating a slowed rate of decay of [Ca2+]i.
⁎P b 0.05.
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activity in HF. On average the slope of the relationship between INCX
and [Ca2+]i was decreased by 24.9 ± 8.7% (Fig. 3C.ii, P b 0.05; 24/9
control; 15/9 heart failure).
3.3. Decreased L-type Ca2+ current and role in altered systolic Ca2+ and SR
Ca2+ content in heart failure
Given that the increase of SR Ca2+ content and reduction in Ca2+
buffering power in HF atrial cells are unable to account for the
decreased Ca2+ transient amplitude observed in HF atrial myocytes,
we next investigated a potential role for changes in the L-type Ca2+ cur-
rent (ICa-L) as this has both trigger and loading roles. The representative
ICa-L records and summary data of Fig. 4A show that HF was associated
with a reduction in the peak ICa-L density (by 36.1 ± 7.8%; control,
2.27 ± 0.14 pA/pF; HF, 1.45 ± 0.15 pA/pF. P b 0.005; 47/20 control;
21/10 heart failure). However, the amount of Ca2+ entry via the L-type
Ca2+ current calculated by integrating ICa-L was unchanged in HF
(control, 0.74 ± 0.06 μmol/l; HF, 0.86 ± 0.09 μmol/l. P = 0.827). TheFig. 4. Decreased ICa-L in HF reduces systolic Ca2+ and increases SR Ca2+ content. A. (i) Repres
(ii) Mean data summarizing peak ICa-L in control and HF atrial myocytes. B. (i) Experimental ti
[Ca2+]i measured using Fura-2. Data obtained on different experimental apparatus and express
and 380 nm. (ii) Mean data summarizing the effect of nicardipine on peak ICa-L. (iii) Mean da
nicardipine on SR Ca2+ content quantiﬁed by the rapid application of caffeine (10mmol/l, solid
(right) of nicardipine (5 μmol/l, open bar). (ii) Mean data summarizing the effect of nicardipinunchanged integrated Ca2+ entry is associatedwith a slowed time course
of inactivation of ICa-L in HF (control, 404 ± 50 s−1; HF, 171 ± 23 s−1,
P b 0.01).
The role that the decreased ICa-L has in producing the smaller Ca2+
transient in HF atrial cells was then investigated using the approach il-
lustrated in Fig. 4B. In control cells, nicardipine (5 μmol/l) was applied
to reduce ICa-L to a similar extent to that observed in HF (Fig. 4B.ii, by
30 ± 15%). This reduction of ICa-L caused a 27 ± 15% decrease in Ca2+
transient amplitude (Fig. 4B.iii, P b 0.01). However, unlike the main-
tained integrated Ca2+ entry via ICa-L in HF atrialmyocytes, the integrat-
ed Ca2+ entry in response to nicardipinewas reduced (from0.9±0.2 to
0.7 ± 0.2 μmol/l; P b 0.01; 8 cells from 4 control hearts). The reduced
integrated Ca2+ entry presumably reﬂects the combined effects of the
decreased peak and unaltered rate of inactivation of the current in
nicardipine. A potential role for altered L-type Ca2+ channel single
channel kinetics in HF, speciﬁcally increased open probability and avail-
ability [40], would also contribute to the differential effects on ICa-L inac-
tivation in HF and nicardipine treated myocytes. Furthermore, the
favoured mode 0 gating of the channel induced by the dihydropyridineentative ICa-L traces elicited by step depolarizations as indicated above the current record.
me course: the application of nicardipine (5 μmol/l) decreases the systolic Ca2+ transient.
ed as pseudo-ratio (R/Rrest) relative to the resting ratio of emitted light excited at 340 nm
ta summarizing the effect of nicardipine on Ca2+ transient amplitude. C. (i) The effect of
bars) to a control cell following steady-state stimulation in the absence (left) and presence
e on SR Ca2+ content. ⁎P b 0.05; ⁎⁎P b 0.01; ⁎⁎⁎P b 0.001.
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tivation between HF and nicardipine treated cells. The effect that the
pharmacological reduction of ICa-L had on SR Ca2+ content is shown in
Fig. 4C. The amplitude of the caffeine evoked rise of [Ca2+]i and inward
NCX current are increased following nicardipine exposure (Fig. 4C.i)
and this resulted in an increase of SR Ca2+ content from 74.1 ± 7.6
μmol/l in control to 89.9 ± 10.5 μmol/l in nicardipine (Fig. 4C.ii, P b
0.01). This data therefore suggests that it is the reduction of ICa-L in HF
atrial cells that is responsible for both the decrease of Ca2+ transient
amplitude and increase of SR Ca2+ content.
Whilst the decrease in ICa-L therefore explains the smaller Ca2+ tran-
sients and increased SR Ca2+ content observed in voltage-clamped cells
we also sought to determine if changes in SERCA or NCX activity also
occur in HF and thusmay contribute to the observed changes in systolic
Ca2+. Firstly we determined if SERCA activity was altered in HF using
the approaches outlined in Fig. 5A. Normalized steady-state systolic
Ca2+ transients from a control and HF atrial cell are shown in Fig. 5B.i
where it is clear that the systolic Ca2+ transient decays more slowly in
HF. This was quantiﬁed by ﬁtting a single exponential to the decay
phase of the Ca2+ transient to obtain the rate constant of decay of sys-
tolic Ca2+ (ksys, Fig. 5B.ii). On average, ksys was reduced by 27.1 ±
6.3% in HF atrial cells (Fig. 5B.iii, Control, 8.99 ± 0.36 s−1; HF, 6.55 ±
0.5 s−1, P b 0.001; 43/18 control; 21/10 HF). The underlyingmechanism
for the reduction of ksys in HF atrial cells was then determined by also
ﬁtting the decay phase of the caffeine evoked Ca2+ transient with a sin-
gle exponential (kcaff). The SR dependent rate of Ca2+ removal (kSR)was
then derived by subtraction (kSR = ksys− kcaff). In HF, sarcolemmal de-
pendent Ca2+ extrusion by NCX and PMCA (kcaff) was increased by
25.2 ± 10% (control, 0.745 ± 0.024 s−1; HF, 0.933 ± 0.069 s−1; P bFig. 5. Slowed rates of decay of systolic Ca2+, reduced SR mediated Ca2+ uptake and enha
illustrating how SR and non-SR dependent rates of Ca2+ removal are calculated in voltag
discharge the SR store. B. (i) Normalized systolic Ca2+ transients from a representative co
the systolic Ca2+ transient (ksys) by ﬁtting (broken line) a single exponential function to the
(iv) Summary data for rate constants of decay of [Ca2+]i due to sarcolemmal extrusion (kcaff) a0.01). Conversely, the SR dependent rate of Ca2+ removal (kSR) was de-
creased (Fig. 5B.iv, Control, 8.1 ± 0.4 s−1; HF, 5.4 ± 0.5 s−1, P b 0.001).
Thus the increase in surfacemembrane-mediated Ca2+ extrusion (kcaff)
is inconsistent with the decrease in the slope of the relationship be-
tween INCX and [Ca2+]i (Fig. 3C). There are at least two possible explana-
tions for this discrepancy; i) an increase in plasmalemmal Ca2+-ATPase
mediated Ca2+ extrusion inHF and, ii) an effect of reduced cellular Ca2+
buffering power (Fig. 3B). The effect of the reduced Ca2+ buffering
power is examined in Supplementary Fig. S.IV. We ﬁnd that during
the systolic Ca2+ transient, in representative cells, CaT falls more
slowly in the HF cell whereas CaT falls more quickly in the HF cell
during the caffeine-evoked Ca2+ transient. In Fig. S.IV.B, the relation-
ship between kcaff and cellular Ca2+ buffering power is examined in
control and HF cells. An inverse correlation (Pearsons correlation co-
efﬁcient, P=0.01) exists indicating that as Ca2+ buffering power de-
creases then kcaff increases. We have also determined, by blocking
NCX with 10 mmol/l Ni2+ and measuring the rate of decay of the
caffeine evoked rise of [Ca2+]i, that the contribution of PMCA to Ca2+
extrusion is no different between control and HF atrial myocytes
(kPMCA: control, 1.17 ± 0.04 s−1; HF, 1.09 ± 0.01 s−1). The unaltered
kPMCA, despite reduced Ca2+ buffering, is further evidence that the
decrease in Ca2+ buffering power in HF accounts for the observed in-
crease in kcaff.
3.4. Molecular correlates of decreased SERCA function and reduced Ca2+
transient amplitude
The next experiments were designed to determine if changes in the
expression and/or phosphorylation status of various proteins involvednced sarcolemmal Ca2+ extrusion in HF atrial myocytes. A. Experimental time course
e-clamped atrial myocytes. Following steady-state stimulation caffeine is applied to
ntrol and HF atrial cell as indicated. (ii) Method for determining the rate of decay of
data. (iii) Summary data for the calculated rates of decay of the systolic Ca2+ transient.
nd SR mediated uptake (ksys). ⁎⁎P b 0.01; ⁎⁎⁎P b 0.001.
Fig. 6.Molecular alterations impacting on atrial cellular Ca2+ handling inHF. A. RepresentativeWestern blots (upper panel) and summary data (lower panel) for (i) SERCA2a, (ii) PLN and,
(iii) summary of the SERCA2a:PLN. B. RepresentativeWestern blots and summary data for (i) Ser16 and (ii) Thr17 phosphorylated PLN. C. Determination of CAMKIIδ expression in heart
failure atria showing Western blot (upper panel) and summary data (lower panel). D. Representative Western blots (upper panel) and summary data (lower panel) for (i) PP1
and, (ii) PP2a expression in HF. E. Increased GRK-2 expression in HF showing representative Western blot (upper panel) and summary data (lower panel). ⁎P b 0.05; ⁎⁎P b 0.01;
⁎⁎⁎P b 0.001.
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in Fig. 5. In each case we used either 6 or 7 hearts from control and HF
animals for biochemical analyes. There was no change in SERCA protein
expression, total PLN expression, the SERCA to PLN expression ratio
(Fig. 6A) or CSQ expression (Supplementary data, Fig. S.V). Using
phospho-speciﬁc antibodies we also examined the phosphorylation
status of PLN (Fig. 6B) and observed that whilst the phosphorylation
status of the PKA-dependent residue (Ser-16) was unaltered in HF,
there was increased phosphorylation at the adjacent Ca2+-calmodulin
kinase II- (CAMKII) dependent Thr-17 residue (to 221± 73% of control,
P b 0.05); an effectmost likely due to the 320±40% increase (relative to
control) in CAMKII expression in HF (Fig. 6C, P b 0.001). The unaltered
PKA-dependent phosphorylation of PLN was associated with an in-
crease in protein phosphatase 1 (PP1; to 159 ± 31%; P b 0.05;
Fig. 6D.i), protein phosphatase 2a (PP2a, to 198 ± 38%; P b 0.01;
Fig. 6D.ii) and G-protein receptor kinase 2 (GRK-2; to 161 ± 32%; P b
0.05; Fig. 6E) expression HF.
We then examined additional molecular correlates of the reduced
Ca2+ transient amplitude observed in HF atria and investigated RyR
expression and phosphorylation at PKA- and CAMKII-dependent sites
(Supplementary data; Fig. S.V). No differences in RyR expression,
PKA-dependent Ser-2808 RyR phosphorylation or CAMKII-dependent
Thr-2814 RyR phosphorylation were observed between control and
HF atrial tissues.
3.5. Restoration of the systolic Ca2+ transient in HF atrial cells by
β-adrenergic stimulation; an effect via the L-type Ca2+ current and SR
Ca2+ content
To determine if the reduced Ca2+ transient observed in HF atrial
cells could be ‘rescued’, we examined the effects of the non-speciﬁc
β-AR agonist isoprenaline (100 nmol/l) on Ca2+ transient amplitude(Fig. 7A.i & ii). Isoprenaline increased Ca2+ transient amplitude in
both control and HF atrial cells although to a greater extent in HF
cells (Fig. 7B.i; control, by 66 ± 8%; HF, by 137 ± 15%; P b 0.001;
24/11 control; 23/5 HF) such that during β-AR stimulation, Ca2+
transient amplitude in HF was indistinguishable from that in control
(not shown). Isoprenaline also accelerated the rate of decay of the
systolic Ca2+ transient in both control and HF atrial cells (ksys,
Fig 7B.ii); an effect attributable to an increase in SERCA activity
with kSR increasing from 1.80 ± 0.36 s−1 to 5.19 ± 0.68 s−1 in con-
trol cells (P b 0.001) and, 0.93 ± 0.17 s−1 to 3.47 ± 0.50 s−1 in HF
atrial cells (Fig. 7B.iii, P b 0.001). Again, during β-AR stimulation HF
and control cells were statistically indistinguishable (ksys, P = 0.145;
kSR, P=0.187). The increase in SERCA activity during β-AR stimulation
also increased SR Ca2+ content in both control (97.0 ± 4.7 to 113.8 ±
7.6 μmol/l, P b 0.001) and HF (145.2 ± 6.4 to 171.1 ± 15.1 μmol/l, P b
0.01) atrial cells (Fig. 7C). However, during β-AR stimulation, SR Ca2+
content was greatest in HF atrial cells (P b 0.001). The isoprenaline-
mediated augmentation of Ca2+ transient amplitudewas also associ-
ated with an increase of L-type Ca2+ current (Fig 7D.i) in both cell
types (Fig. 7D.ii, control, 4.26 ± 0.35 pA/pF; HF, 2.81 ± 0.36 pA/pF;
P b 0.001) although peak ICa-L was smaller in HF cells than in control
cells (P b 0.05). In ISO the integrated Ca2+ entry on ICa-L was indistin-
guishable between control and HF mycoytes. Finally, by Western
blotting we were unable to detect differences in the expression of
the G-proteins Gαs and Gαi(1/2/3) (Supplementary data; Fig S.VI).
3.6. The effects of HF-induced changes to intracellular Ca2+ homeostasis on
cellular Ca2+ economy in the atria
The previous sections highlight multiple changes in cellular Ca2+
homeostasis in atrial cells occurring in HF. How these impact on the
total Ca2+ economy of the cell are summarized in Table 1. The systolic
Fig. 7. Normalization of the systolic Ca2+ transient and impact of β-AR stimulation on cellular Ca2+ homeostasis in HF atrial myocytes. A. Representative experimental time course from
representative control (i) and HF (ii) cells. Cells were voltage-clamped and stimulated in the presence of 100 nmol/l isoprenaline as indicated above the records. Panels show steady-state
effects. [Ca2+]i measured with Fura-2. Data obtained on different experimental apparatus and expressed as a pseudo-ratio (R/Rrest) relative to the resting ratio of emitted light excited at
340 nm and 380 nm. B. (i) Isoprenaline mediated increase in Ca2+ transient amplitude. (ii) Summary data for effect of β-AR stimulation on the rate of decay of the systolic Ca2+ transient
(ksys). (iii) Summary data for effect of β-AR stimulation on the SR dependent rate of Ca2+ removal (kSR). C. Summary data for increase in SR Ca2+ content during β-AR stimulation.
D. (i) Representative ICa-L records from control and HF atrial myocytes under basal stimulation and following β-AR stimulation as indicated. (ii)Mean data summarizing the effect of β-AR
stimulation on peak ICa-L density. ⁎⁎P b 0.01; ⁎⁎⁎P b 0.001.
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of the decreased Ca2+ buffering power (β) of the cell in HF the total
Ca2+ requirement to generate the systolic Ca2+ transient is decreased
by 59 ± 7% (P b 0.001). This total Ca2+ requirement is met from two
sources; i) Ca2+ entry via ICa-L and, ii) the release of Ca2+ from the SR.
Given that the integrated Ca2+ entry via ICa-L is unaltered and SR Ca2+
content is increased in HF, it is not surprising therefore that the fraction-
al release of Ca2+ from the SR is reduced in HF by 64 ± 7% (P b 0.001).
Finally, the gain of excitation contraction coupling can be calculated
from the integrated Ca2+ entry and release of Ca2+ from the SR during
the systolic Ca2+ transient is reduced by 67 ± 7% (P b 0.001) in HF.Table 1
Modelling the effects of Ca2+ handling alterations in heart failure on systolic Ca2+.
Summary of how HF affects the total Ca2+ economy of the cell. ns, not signiﬁcant; *,
P b 0.05; #, P b 0.01 and §, P b 0.001. The following equations were used to calculate
the indicated parameters: Ca2+ buffering power (β) = Δ Ca2+ total/Δ [Ca2+]i; Total
Ca2+ transient = β ∗ Δ [Ca2+]i; systolic Δ SR Ca2+ content = SR Ca2+ content − (Total
Ca2+ − ICa-L); SR fractional release = Systolic Δ SR Ca2+/SR Ca2+ content; EC coupling
gain = Systolic Δ SR Ca2+/ ICa-L.
Control
Atrial cell (n = 43)
Heart failure
Atrial cell (n = 21)
Δ systolic [Ca2+]i (nmol/l) 83 ± 6 60 ± 6#
Ca2+ buffering power (β) 565 ± 41 318 ± 29§
Total Ca2+ transient (μmol/l) 46.9 ± 4.8 19.1 ± 2.6§
Integrated ICa-L (μmol/l) 0.74 ± 0.06 0.86 ± 0.09ns
SR Ca2+ content (μmol/l) 83.9 ± 4.5 100.1 ± 6.7⁎
Δ SR Ca2+ systole (μmol/l) 46.2 ± 4.8 18.2 ± 2.6§
SR fractional release 0.55 ± 0.06 0.18 ± 0.03§
EC coupling gain 62.4 ± 8.2 21.2 ± 3.8§4. Discussion
The main ﬁndings from the present work are that in failing hearts
atrial myocytes, i) are hypertrophied, ii) have smaller systolic Ca2+
transients that decay more slowly, iii) have a reduction in ICa,L, iv)
have a reduced Ca2+ buffering power and, iv) have a greater increase
in Ca2+ transient amplitude in response toβ-AR stimulation. The reduc-
tion of ICa-L is sufﬁcient to explain the smaller systolic Ca2+ transient
and the accompanying increased SR Ca2+ content observed in voltage
clamped cells. The reduced Ca2+ buffering capacity of HF atrial
myocytes is insufﬁcient to maintain systolic Ca2+, but it does facilitate
the enhanced sarcolemmal-mediated rate of Ca2+ extrusion observed
inHF atrialmyocytes. The restoration of systolic Ca2+ duringβ-AR stim-
ulation likely occurs as a result of increases in ICa-L and SR Ca2+ content.
The above changes in cellular Ca2+ homeostasis provide a mechanism
for the reduction in Ca2+ transient amplitude observed in atrial
myocytes isolated from failing hearts.
4.1. Cellular remodelling in heart failure
Two major considerations in the present manuscript are how HF
induced by right ventricular tachypacing mediates changes in cellular
geometry and atrial cellular Ca2+ homeostasis. As such it is important
to note (Supplementary material, Fig S.VII) that the high ventricular
pacing rate used to initiate HF does not increase atrial rate. The changes
in Ca2+ homeostasis and cellular remodelling are therefore not due to
atrial tachypacing in contrast to those observed in various models of
atrial ﬁbrillation e.g. [42,43]. In order to quantify the HF-induced chang-
es in cellular Ca2+ cycling, a measure of the surface area to volume ratio
is required to relate sarcolemmal Ca2+ ﬂuxes and SR Ca2+ content to
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hypertrophied showing a ~20% increase in cell diameter, ~30% increase
in cell length and ~70% increase in cell depth. Both the increase of cell
dimensions and loss of t-tubules that occurs in atrial cells in this HF
model [27] would be expected to decrease the surface area to volume
ratio. However, such a decrease is not observed in experiments where
cell volume is derived from confocal z-stacks of calcein loaded cells
patch-clamped to obtain a simultaneous measure of cell volume and
membrane capacitance (surface area). Indeed, the HF and control cell
data ﬁt on precisely the same surface area (capacitance) to volume rela-
tionship even though their surface area and volume values overlapmin-
imally. There are at least two potential factors that could explain the
apparent constancy of the surface area to volume ratio in HF despite
the cellular hypertrophy and loss of t-tubules [27]; i) the depth of the
cells increased fractionally more than cell width consequently changing
the expected shift in surface area to volume ratio (which is ‘based’ on
the assumption that cells are ‘cylindrical’) and, ii) atrial dilatation may
have stretched the cells and incorporated sub-membrane caveolae
into the surface membrane and thus increased the apparent surface
area to volume ratio. Sub-membrane caveolar incorporation has been
suggested previously in acutely stretched myocytes [44]. Such effects
would result in an increase in the observed surface area to volume
ratio over that predicted from the changes in cellular planar dimensions.
4.2. Decreased ICa-L can explain the smaller systolic Ca
2+ transient and
paradoxical increase of SR Ca2+ content in voltage-clamped HF atrial cells
We ﬁnd that a decrease of ICa-L accompanied the observed decrease
of the systolic Ca2+ transient. Such a decrease of atrial ICa-L has been ob-
served previously in variousmodels of cardiac disease e.g. [42,43,45,46].
That the decrease in ICa-L is causal of the decreased Ca2+ transient is
demonstrated by the observation that pharmacologically inhibiting
ICa-L in control cells with nicardipine reproduces the effect of HF on
ICa-L, Ca2+ transient amplitude and SR Ca2+ content. Whilst we do not
have data for changes in dihydropyridine binding or L-type Ca2+ chan-
nel α-subunit expression in the atria in HF, the loss of atrial t-tubules
that occurs in this model of HF [27] is likely to contribute to the fall in
ICa-L [47].
The decrease of ICa-L may also explain the observed increase of SR
Ca2+ content in voltage-clamped myocytes. The L-type Ca2+ current
has two effects on SR Ca2+; i) it triggers release and therefore an
increase of ICa-L would be expected to decrease SR Ca2+ and, ii) on the
other hand it loads the cell and therefore the SR with Ca2+. It is there-
fore difﬁcult to predict the net effect of change in ICa-L on SR Ca2+ con-
tent. We ﬁnd that in the atria, as in the ventricle [5,18,48], reducing
ICa-L leads to an increase of SR Ca2+ content. However, the increase in
SR Ca2+ content is insufﬁcient to restore the systolic Ca2+ transient
which remains smaller in HF atrial myocytes despite the increase in
SR Ca2+ content.
4.3. Altered cellular Ca2+ buffering and t-tubule loss in heart failure
Whilst the smaller systolic Ca2+ transient observed in HF atrial cells
can be mimicked in control cells by inhibition of ICa-L with nicardipine,
additional factors regulating the systolic Ca2+ transient also change in
HF. These include, i) reductions in the Ca2+ buffering capacity and,
ii) a decrease in the gain of excitation contraction coupling. The net
effect of these changes however remains a smaller rise of Ca2+ in HF
atrial cells. A key factor likely contributing to the reduction in excitation
contraction coupling gain is the reduction in peak (trigger) ICa-L in HF.
Again, the loss of t-tubules in HF atrial myoyctes [27,42,49] and hence
reduction in ICa-L [47,50] is therefore likely an important factor in the
decrease in Ca2+ transient amplitude we observe in HF atrial cells in
the sheep.
The ﬁnding in the present study that, despite the reported loss of
t-tubules in HF atrial myocytes [27], the relationship between NCXcurrent and [Ca2+]i is reduced in HF is consistent with either a reduc-
tion of NCX expression at the cell surface in HF or, if this is unaltered,
an increased density of NCX on the t-tubules which have subsequently
been lost in HF. Given the importance of NCX in arrhythmogenesis via
Ca2+ dependent mechanisms we would suggest that, on balance, the
decrease in NCX current we see in this model of end-stage heart failure
might mean that other mechanisms e.g. as a result of action potential
shortening or K+ current remodelling, may be more important in
increasing the susceptibility of the atria to arrhythmias in HF. However,
it is important to note that the data presented here is from a model of
end-stage heart failure where contractile dysfunction rather than
arrhythmias may be more pathologically relevant.
4.4. β-Adrenergic stimulation and restoration of the systolic Ca2+ transient
in HF atrial myocytes: potential importance in arrhythmia initiation
In the present study we ﬁnd that, during β-AR stimulation, the
amplitude of the systolic Ca2+ transient in HF atrial cells is indistin-
guishable from that of control cells. However, neither the rate of decay
of the systolic Ca2+ transient (ksys) nor SR dependent rate of Ca2+ re-
moval (kSR) is fully restored by β-AR stimulation. Nevertheless, SR
Ca2+ content is increased by β-AR stimulation in both control and HF
cells and importantly, in HF cells, SR Ca2+ content remains greater
than in control cells. It is therefore likely that the combined effect of
increasing SR Ca2+ content and ICa-L during β-AR stimulation is respon-
sible for normalizing systolic Ca2+ in HF atrial myocytes. Thus, during
β-AR stimulation the increase in excitation contraction coupling gain
and fractional release of Ca2+ from the SR [51] facilitate the propagation
of the peripheral Ca2+ transient to the cell centre and restore systolic
Ca2+ despite the loss of atrial t-tubules in HF [27,52].
Although not addressed speciﬁcally in the present study, due to the
difﬁculty in quantitatively measuring changes of SR Ca2+ content from
the amplitude of the caffeine evoked Ca2+ transient, should SR Ca2+
content preferentially increase during β-AR stimulation in HF atrial
cells following current clamp stimulation (the in vivo situation) this
would also provide a conducive pathway to DAD formation and act as
an important precursor for new onset AF [10]. However, despite the po-
tential effects of changes in SR Ca2+ content following β-AR stimulation
during current clamp stimulation, the shorter action potential duration
noted in HF atrial cells, via reductions in effective refractory period
would also serve to promote arrhythmias although via re-entrant
mechanisms.
4.5. Molecular correlates of altered cellular Ca2+ homeostasis and β-AR
responsiveness in heart failure atrial myocytes
A major observation in the present study is that SERCA activity is
reduced in HF atrial cells resulting in reductions to the rate of decay of
the systolic Ca2+ transient and SR dependent Ca2+ uptake. Whilst
changes in SERCA expression or activity have only modest effects on
SR Ca2+ content [53,54] (due to the shallow dependence of SR Ca2+
content on SERCA activity [55]), we noted that SR Ca2+ content was
increased in voltage-clamped HF atrial cells. Importantly, the changes
in SERCA activity were noted despite the decrease in Ca2+ buffering
power and therefore, as presented, likely represent an underestimate
of the actual decrease in SERCA function. Whilst we were unable to
detect changes in SERCA, total PLN, Ser-16 phosphorylated PLN or the
ratio of PLN to SERCA, we did observe an increase in Thr-17 phosphory-
lated PLN, CAMKII, PP1, PP2a and GRK-2 expression. Thus the reported
changes in protein expression in HF atria do not readily account for
the observed reduction in SERCA activity. In the atria SERCA is also reg-
ulated by an additional protein, sarcolipin [56]. However, due to a lack of
suitable antibodies we have been unable to investigate whether or not
sarcolipin expression alters in HF atrial myocytes and can explain the
decrease in SERCA activity we observe.
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and ICa-L in HF atrial cells is consistent with the increased expression of
theG-protein receptor kinase GRK-2 [57]. Similarﬁndings have been re-
ported previously in the ventricle in various models of cardiac disease
e.g. [5,58]. However, given the effect that reducing ICa-L has on SR
Ca2+ content, the increases in GRK-2, PP1 and PP2a may be important
in maintaining the increased SR Ca2+ content in HF atrial cells during
β-AR stimulation because they attenuate any β-AR mediated increase
in ICa,L.4.6. Study limitations
We have examined how intracellular Ca2+ homeostasis and the
response to catecholamine stimulation are altered in the atria in HF.
Whilst the changes in cellular Ca2+ homeostasis and, in particular SR
Ca2+ content, may provide a substrate for the generation of Ca2+
dependent arrhythmias we have not established if the threshold SR
Ca2+ content is altered in HF, if HF atrial myocytes are more excitable
due to concomitant alterations in K+ channel expression or function
e.g. [15] and whether ultimately AF is more readily induced and main-
tained in this model of HF. However, in a comparable model of
tachypacing induced HF in the dog, an increased susceptibility to, and
stability of, AF has been reported [59] and, at the single cell level, spon-
taneous SR Ca2+ release and DADs were more prevalent in HF atrial
myocytes [20]. For the measurements of ICa-L a holding potential of
−40mVwas used andwe did not correct for any liquid junction poten-
tial artefacts (~8 mV).
For the in vivo assessments of cardiac function by ECG and echo-
cardiography animals were gently restrained. As such we cannot
exclude the possibility that adrenergic outﬂow may be inﬂuencing
our measures of cardiac function in both control and HF animals;
and potentially differentially. However, the use of sedation or per-
forming such measurements in anaesthetized animals would also be
expected to inﬂuence these measurements and again may do so
differentially.
In the present study we have usedWestern blotting to measure the
expression of protein phosphatases and kinases and have not investi-
gated their activity directly. However, the expression of protein phos-
phatases and G-protein receptor kinases has previously been
demonstrated to correlate directly with their activity [60,61]. Thus,
our observation of increased PP1, PP2a and GRK-2 expression is consis-
tent with the reduced SR Ca2+ uptake rate and impaired ICa-L that are
present under basal and β-AR stimulation conditions in HF atrial
myocytes. Moreover, we did not determine if changes in PMCA activity
occur in this model of HF and therefore whether the correction factor
non-NCX mediated Ca2+ extrusion differs between control and HF
myocytes. However, even if PMCA activity were to change by 50% this
would result in an under or overestimation of SR Ca2+ content by less
than 10%.5. Conclusions
In summarywe describe a number of changes to atrial Ca2+ homeo-
stasis that occur as a consequence of HF induced by right ventricular
tachypacing. Speciﬁcally, the decrease in ICa-L and previously reported
loss of atrial t-tubules in this model of HF serve to decrease the systolic
Ca2+ transient amplitude and increase SR Ca2+ content in voltage-
clamped cells. However, the changes in SR Ca2+ content observed in
voltage-clamped cells, are insufﬁcient to prevent the smaller rise of sys-
tolic Ca2+. Similarly, the observed decrease in cellular Ca2+ buffering
capacity is also insufﬁcient to maintain systolic Ca2+ although it does
contribute to an increased rate of Ca2+ removal from the cell via the sar-
colemmal pathways despite the reduction in NCX current in the atria in
heart failure.Funding
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